[The effect of caffeine on the serum insulin level during intravenous glucose tolerance test in patients with chemical diabetes]. 1976

H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner

Nine mild male diabetic patients were studied by intravenous glucose tolerance tests with and without pretreatment with caffeine. The dose of caffeine was 90 mg given as 195 mg of caffeine citrate. The parameters measured were blood glucose and serum insulin. Caffeine given 2 hours previously did not affect the mean glucose disappearance rate of the group, however, those with the highest rates did show a reduced rate after caffeine. Insulin levels showed a decrease particularly during the first five minutes after glucose. This finding was present particularly in those patients who exhibited the larger first peak. It is possible that a relationship exists between the magnitude of the caffeine effect upon early insulin secretion and the glucose disappearance rate.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
February 1973, Metabolism: clinical and experimental,
H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
December 1968, The Australian journal of experimental biology and medical science,
H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
November 1976, Vnitrni lekarstvi,
H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
November 1999, Zhonghua nei ke za zhi,
H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
November 2008, Diabetes research and clinical practice,
H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
July 1981, Canadian Anaesthetists' Society journal,
H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
May 1996, Metabolism: clinical and experimental,
H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
January 1954, The Journal of clinical investigation,
H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
April 2013, Interface focus,
H P Ammon, and R L Kaufmann, and J Steinke, and C B Kahn, and J S Soeldner
March 1991, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!